National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 12915 [2016-05430]
Download as PDF
<![CDATA[
12915
Federal Register / Vol. 81, No. 48 / Friday, March 11, 2016 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses per
respondent
Average time
per response
(in hours)
Total annual
burden hours
Type of respondents
Forms
Clinical Research Administrators ..........................
Initial Registration .........
Amendment ..................
Accrual Updates ...........
3,000
3,000
3,000
1
4
4
1
1
15/60
3,000
12,000
3,000
Totals .............................................................
.......................................
9,000
27,000
........................
18,000
Dated: March 2, 2016.
Karla Bailey,
Project Clearance Liaison, National Cancer
Institute, NIH.
Dated: March 4, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–05425 Filed 3–10–16; 8:45 am]
[FR Doc. 2016–05430 Filed 3–10–16; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
NIH Pathways to Prevention
Workshop: Advancing Research To
Prevent Youth Suicide
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Nonhuman Primate Reagent
Resource (U24).
Date: April 8, 2016.
Time: 10:30 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Nancy VazquezMaldonado, Ph.D., Scientific Review Officer,
Scientific Review Program, Division of
Extramural Activities, Room 3F52B, National
Institutes of Health/NIAID, 5601 Fishers
Lane, MSC 9834, Bethesda, MD 20892–9834,
(240) 669–5044, nvazquez@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
VerDate Sep<11>2014
17:56 Mar 10, 2016
Jkt 238001
The National Institutes of
Health (NIH) will host a workshop on
Advancing Research To Prevent Youth
Suicide on March 29–30, 2016. The
workshop is free and open to the public.
DATES: March 29, 2016, from 8:30 a.m.–
4:50 p.m. and March 30, 2016, from 8:30
a.m.–1:00 p.m.
ADDRESSES: The workshop will be held
at the NIH, Masur Auditorium, Building
10 (Clinical Center), 9000 Rockville
Pike, Bethesda, Maryland 20892.
Registration and workshop information
are available on the NIH Office of
Disease Prevention (ODP) Web site at
<https://prevention.nih.gov/p2psp>.
FOR FURTHER INFORMATION CONTACT: For
further information concerning this
workshop, contact the ODP at
<NIHP2P@mail.nih.gov>, 6100
Executive Blvd., Room 2B03, MSC 7523,
Bethesda, MD 20892–7523; Telephone:
301–496–1508; FAX: 301–480–7660.
SUPPLEMENTARY INFORMATION: Suicide
was the second leading cause of death
for youth (10- to 24-year-olds) in 2014,
resulting in 5,504 deaths in the United
States. This mortality has not decreased
compared to other external causes of
death, and youth suicide attempts have
remained at consistent rates for decades.
According to the 2011 Youth Risk
Behavior Surveillance System, 2.4% of
high school students received medical
treatment for attempted suicide, and
7.8% attempted suicide one or more
times within the year. Some groups
(e.g., American Indian youth; young
adults with substance use problems;
SUMMARY:
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
children of depressed parents; youth
and young adults who identify as a
sexual and gender minority) are at
increased risk for suicidal behaviors.
One of the challenges in suicide
prevention research is that the primary
outcome of interest is multidetermined
and, depending on the target
population, suicide can be a low base
rate occurrence. Many studies
examining risk in important subgroups
(e.g., racial, ethnic, sexual and gender
minorities) often lack sufficient power
to accurately determine the
effectiveness of the intervention.
Because suicidal behavior is often
multidetermined, it may be that
interventions addressing suicide risk
factors have benefits for suicide
reduction, but these benefits are not
obvious in research findings, nor can
the larger community know of these
benefits. Pooling studies and being able
to link data from individual studies to
multiple data surveillance systems
would be important to better understand
the effectiveness of prevention strategies
on outcomes such as suicide, suicide
attempts, and suicide ideation.
Preventing attempts and self-harm
ideation would likely result in a
reduction in deaths, as well as
reductions in health care and social
burden associated with suicidal
behavior.
Closing the research gaps related to
youth suicide could lead to improved
prevention strategies. The NIH is
engaging in a rigorous assessment of the
available scientific evidence to better
understand the importance of
identifying efforts that could be effective
in preventing suicidal thoughts and
behaviors as early as possible. The
National Institute of Mental Health, the
National Institute on Drug Abuse, the
National Center for Complementary and
Integrative Health, and the NIH Office of
Disease Prevention (ODP) are
sponsoring the Pathways to Prevention
Workshop: Advancing Research To
Prevent Youth Suicide on March 29–30,
2016, in Bethesda, Maryland. The
workshop will evaluate the current state
of knowledge on youth suicide and
identify opportunities for future
E:\FR\FM\11MRN1.SGM
11MRN1
]]>Agencies
[Federal Register Volume 81, Number 48 (Friday, March 11, 2016)]
[Notices]
[Page 12915]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-05430]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Nonhuman Primate Reagent Resource
(U24).
Date: April 8, 2016.
Time: 10:30 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 5601 Fishers Lane,
Rockville, MD 20892 (Telephone Conference Call).
Contact Person: Nancy Vazquez-Maldonado, Ph.D., Scientific
Review Officer, Scientific Review Program, Division of Extramural
Activities, Room 3F52B, National Institutes of Health/NIAID, 5601
Fishers Lane, MSC 9834, Bethesda, MD 20892-9834, (240) 669-5044,
nvazquez@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: March 4, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-05430 Filed 3-10-16; 8:45 am]
BILLING CODE 4140-01-P
